{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:56:10Z","timestamp":1791186970299,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.82360161, NO.81960155 and NO.81270889"],"award-info":[{"award-number":["NO.82360161, NO.81960155 and NO.81270889"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Scientific and Technological Innovation Project of Health Industry in Gansu Province","award":["NO.GSWSZD2025-07"],"award-info":[{"award-number":["NO.GSWSZD2025-07"]}]},{"name":"Gansu Joint Research Fund","award":["NO.24JRRA918"],"award-info":[{"award-number":["NO.24JRRA918"]}]},{"name":"Science and Technology planning project of Lanzhou City","award":["No. 2022-3-46"],"award-info":[{"award-number":["No. 2022-3-46"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05670-3","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:52:58Z","timestamp":1785747178000},"page":"4497-4525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liraglutide affects mitochondrial function and histone acetylation through the NQO1\/SIRT3 pathway in diabetic kidney disease"],"prefix":"10.1007","volume":"481","author":[{"given":"Jie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"1","key":"5670_CR1","doi-asserted-by":"publisher","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","volume":"10","author":"X Lin","year":"2020","unstructured":"Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X et al (2020) Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep 10:14790. https:\/\/doi.org\/10.1038\/s41598-020-71908-9","journal-title":"Sci Rep"},{"key":"5670_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151","journal-title":"Nat Rev Endocrinol"},{"key":"5670_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","volume":"16","author":"M Ruiz-Ortega","year":"2020","unstructured":"Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR (2020) Targeting the progression of chronic kidney disease. Nat Rev Nephrol 16:269\u2013288. https:\/\/doi.org\/10.1038\/s41581-019-0248-y","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 1","key":"5670_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","volume":"22","author":"NM Selby","year":"2020","unstructured":"Selby NM, Taal MW (2020) An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab 22(Suppl 1):3\u201315. https:\/\/doi.org\/10.1111\/dom.14007","journal-title":"Diabetes Obes Metab"},{"key":"5670_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","volume":"32","author":"P Belenky","year":"2007","unstructured":"Belenky P, Bogan KL, Brenner C (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32:12\u201319","journal-title":"Trends Biochem Sci"},{"key":"5670_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0009-2797(00)00199-X","volume":"129","author":"D Ross","year":"2000","unstructured":"Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D (2000) NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 129:77\u201397","journal-title":"Chem Biol Interact"},{"key":"5670_CR7","doi-asserted-by":"publisher","first-page":"8907","DOI":"10.1007\/s11033-022-07369-2","volume":"49","author":"S Preethi","year":"2022","unstructured":"Preethi S, Arthiga K, Patil AB, Spandana A, Jain V (2022) Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway. Mol Biol Rep 49:8907\u20138924. https:\/\/doi.org\/10.1007\/s11033-022-07369-2","journal-title":"Mol Biol Rep"},{"key":"5670_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017963","volume":"6","author":"RH Haefeli","year":"2011","unstructured":"Haefeli RH, Erb M, Gemperli AC, Robay D, Courdier Fruh I, Anklin C et al (2011) NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One 6:e17963. https:\/\/doi.org\/10.1371\/journal.pone.0017963","journal-title":"PLoS One"},{"key":"5670_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.arr.2006.03.005","volume":"5","author":"D-H Hyun","year":"2006","unstructured":"Hyun D-H, Hernandez JO, Mattson MP, de Cabo R (2006) The plasma membrane redox system in aging. Ageing Res Rev 5:209\u2013220","journal-title":"Ageing Res Rev"},{"key":"5670_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/ars.2016.6682","volume":"25","author":"A Benigni","year":"2016","unstructured":"Benigni A, Perico L, Macconi D (2016) Mitochondrial dynamics is linked to longevity and protects from end-organ injury: the emerging role of sirtuin 3. Antioxid Redox Signal 25:185\u2013199. https:\/\/doi.org\/10.1089\/ars.2016.6682","journal-title":"Antioxid Redox Signal"},{"key":"5670_CR11","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMra1100831","volume":"364","author":"L Guarente","year":"2011","unstructured":"Guarente L (2011) Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med 364:2235\u20132244. https:\/\/doi.org\/10.1056\/NEJMra1100831","journal-title":"N Engl J Med"},{"key":"5670_CR12","doi-asserted-by":"publisher","first-page":"745279","DOI":"10.3389\/fmed.2021.745279","volume":"8","author":"DL Galvan","year":"2021","unstructured":"Galvan DL, Mise K, Danesh FR (2021) Mitochondrial regulation of diabetic kidney disease. Front Med (Lausanne) 8:745279. https:\/\/doi.org\/10.3389\/fmed.2021.745279","journal-title":"Front Med (Lausanne)"},{"key":"5670_CR13","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1681\/ASN.2010010046","volume":"21","author":"CM Hao","year":"2010","unstructured":"Hao CM, Haase VH (2010) Sirtuins and their relevance to the kidney. J Am Soc Nephrol 21:1620\u20131627. https:\/\/doi.org\/10.1681\/ASN.2010010046","journal-title":"J Am Soc Nephrol"},{"key":"5670_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65423-0","volume":"10","author":"M Locatelli","year":"2020","unstructured":"Locatelli M, Zoja C, Zanchi C, Corna D, Villa S, Bolognini S et al (2020) Manipulating sirtuin 3 pathway ameliorates renal damage in experimental diabetes. Sci Rep 10:8418. https:\/\/doi.org\/10.1038\/s41598-020-65423-0","journal-title":"Sci Rep"},{"key":"5670_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03197-3","volume":"20","author":"D Qiu","year":"2022","unstructured":"Qiu D, Song S, Wang Y, Bian Y, Wu M, Wu H et al (2022) NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy. J Transl Med 20:44. https:\/\/doi.org\/10.1186\/s12967-021-03197-3","journal-title":"J Transl Med"},{"key":"5670_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104975","volume":"299","author":"K Myakala","year":"2023","unstructured":"Myakala K, Wang XX, Shults NV, Krawczyk E, Jones BA, Yang X et al (2023) NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease. J Biol Chem 299:104975. https:\/\/doi.org\/10.1016\/j.jbc.2023.104975","journal-title":"J Biol Chem"},{"key":"5670_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/1753-0407.12969","volume":"11","author":"LA Sloan","year":"2019","unstructured":"Sloan LA (2019) Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects. J Diabetes 11:938\u2013948. https:\/\/doi.org\/10.1111\/1753-0407.12969","journal-title":"J Diabetes"},{"key":"5670_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1479-5876-11-270","volume":"11","author":"YT Chen","year":"2013","unstructured":"Chen YT, Tsai TH, Yang CC, Sun CK, Chang LT, Chen HH et al (2013) Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 11:270. https:\/\/doi.org\/10.1186\/1479-5876-11-270","journal-title":"J Transl Med"},{"key":"5670_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.18388\/abp.2017_1634","volume":"64","author":"J G\u00f3ralska","year":"2017","unstructured":"G\u00f3ralska J, \u015aliwa A, Gruca A, Ra\u017any U, Chojnacka M, Polus A et al (2017) Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes. Acta Biochim Pol 64:423\u2013429. https:\/\/doi.org\/10.18388\/abp.2017_1634","journal-title":"Acta Biochim Pol"},{"key":"5670_CR20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s13577-024-01038-1","volume":"37","author":"L Hou","year":"2024","unstructured":"Hou L, Du J, Dong Y, Wang M, Wang L, Zhao J (2024) Liraglutide prevents cellular senescence in human retinal endothelial cells (HRECs) mediated by SIRT1: an implication in diabetes retinopathy. Hum Cell 37:666\u2013674. https:\/\/doi.org\/10.1007\/s13577-024-01038-1","journal-title":"Hum Cell"},{"key":"5670_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","volume":"52","author":"K Srinivasan","year":"2005","unstructured":"Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P (2005) Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313\u2013320","journal-title":"Pharmacol Res"},{"key":"5670_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jcmm.13967","volume":"23","author":"E Kornelius","year":"2018","unstructured":"Kornelius E, Li H-H, Peng C-H, Yang Y-S, Chen W-J, Chang Y-Z et al (2018) Liraglutide protects against glucolipotoxicity-induced RIN-m5F \u03b2-cell apoptosis through restoration of PDX1 expression. J Cell Mol Med 23:619\u2013629. https:\/\/doi.org\/10.1111\/jcmm.13967","journal-title":"J Cell Mol Med"},{"key":"5670_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179672","volume":"12","author":"W Zhang","year":"2017","unstructured":"Zhang W, Su J, Xu H, Yu S, Liu Y, Zhang Y et al (2017) Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells. PLoS One 12:e0179672. https:\/\/doi.org\/10.1371\/journal.pone.0179672","journal-title":"PLoS One"},{"key":"5670_CR24","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.metabol.2012.03.002","volume":"61","author":"H Hendarto","year":"2012","unstructured":"Hendarto H, Inoguchi T, Maeda Y, Ikeda N, Zheng J, Takei R et al (2012) GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. Metabolism 61:1422\u20131434. https:\/\/doi.org\/10.1016\/j.metabol.2012.03.002","journal-title":"Metabolism"},{"key":"5670_CR25","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nprot.2007.202","volume":"2","author":"D Shechter","year":"2007","unstructured":"Shechter D, Dormann HL, Allis CD, Hake SB (2007) Extraction, purification and analysis of histones. Nat Protoc 2:1445\u20131457","journal-title":"Nat Protoc"},{"key":"5670_CR26","doi-asserted-by":"publisher","first-page":"F644","DOI":"10.1152\/ajprenal.00417.2023","volume":"326","author":"SR McKinzie","year":"2024","unstructured":"McKinzie SR, Kaverina N, Schweickart RA, Chaney CP, Eng DG, Pereira BMV et al (2024) Podocytes from hypertensive and obese mice acquire an inflammatory, senescent, and aged phenotype. Am J Physiol Ren Physiol 326:F644\u2013F660. https:\/\/doi.org\/10.1152\/ajprenal.00417.2023","journal-title":"Am J Physiol Ren Physiol"},{"key":"5670_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ebiom.2016.03.033","volume":"7","author":"S Miyamoto","year":"2016","unstructured":"Miyamoto S, Hsu C-C, Hamm G, Darshi M, Diamond-Stanic M, Decl\u00e8ves A-E et al (2016) Mass spectrometry imaging reveals elevated glomerular ATP\/AMP in diabetes\/obesity and identifies sphingomyelin as a possible mediator. EBioMedicine 7:121\u2013134. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.033","journal-title":"EBioMedicine"},{"key":"5670_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10715762.2018.1549732","volume":"53","author":"J Wu","year":"2019","unstructured":"Wu J, Zeng Z, Zhang W, Deng Z, Wan Y, Zhang Y et al (2019) Emerging role of SIRT3 in mitochondrial dysfunction and cardiovascular diseases. Free Radic Res 53:139\u2013149. https:\/\/doi.org\/10.1080\/10715762.2018.1549732","journal-title":"Free Radic Res"},{"key":"5670_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11091745","volume":"11","author":"J Qiu","year":"2022","unstructured":"Qiu J, Liu D, Li P, Zhou L, Zhou L, Liu X et al (2022) NADPH oxidase mediates oxidative stress and ventricular remodeling through SIRT3\/FOXO3a pathway in diabetic mice. Antioxidants (Basel) 11:1745. https:\/\/doi.org\/10.3390\/antiox11091745","journal-title":"Antioxidants (Basel)"},{"key":"5670_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41419-018-1169-6","volume":"10","author":"Y Peng","year":"2019","unstructured":"Peng Y, Yang C, Shi X, Li L, Dong H, Liu C et al (2019) Sirt3 suppresses calcium oxalate-induced renal tubular epithelial cell injury via modification of FoxO3a-mediated autophagy. Cell Death Dis 10:34. https:\/\/doi.org\/10.1038\/s41419-018-1169-6","journal-title":"Cell Death Dis"},{"key":"5670_CR31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1875-5364(16)30068-1","volume":"14","author":"HY Liu","year":"2016","unstructured":"Liu HY, Li QR, Cheng XF, Wang GJ, Hao HP (2016) NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells. Chin J Nat Med 14:582\u2013589. https:\/\/doi.org\/10.1016\/S1875-5364(16)30068-1","journal-title":"Chin J Nat Med"},{"key":"5670_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74493-z","volume":"10","author":"SJ Moon","year":"2020","unstructured":"Moon SJ, Jeong JY, Kim JH, Choi DH, Choi H, Chang YK et al (2020) The potential roles of NAD(P)H:quinone oxidoreductase 1 in the development of diabetic nephropathy and actin polymerization. Sci Rep 10:17735. https:\/\/doi.org\/10.1038\/s41598-020-74493-z","journal-title":"Sci Rep"},{"key":"5670_CR33","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1021\/acs.jproteome.2c00167","volume":"21","author":"C Luo","year":"2022","unstructured":"Luo C, Ding W, Yang C, Zhang W, Liu X, Deng H (2022) Nicotinamide mononucleotide administration restores redox homeostasis via the Sirt3-Nrf2 axis and protects aged mice from oxidative stress-induced liver injury. J Proteome Res 21:1759\u20131770. https:\/\/doi.org\/10.1021\/acs.jproteome.2c00167","journal-title":"J Proteome Res"},{"key":"5670_CR34","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1039\/d3fo05025d","volume":"15","author":"L Zhao","year":"2024","unstructured":"Zhao L, Zhang X, Chen Z, Lai Y, Xu J, Zhou R et al (2024) Cynarin alleviates acetaminophen-induced acute liver injury through the activation of Keap1\/Nrf2-mediated lipid peroxidation defense via the AMPK\/SIRT3 signaling pathway. Food Funct 15:4954\u20134969. https:\/\/doi.org\/10.1039\/d3fo05025d","journal-title":"Food Funct"},{"key":"5670_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/ars.2018.7620","volume":"31","author":"H Feng","year":"2019","unstructured":"Feng H, Wang JY, Yu B, Cong X, Zhang WG, Li L et al (2019) Peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1 inhibits vascular calcification through sirtuin 3-mediated reduction of mitochondrial oxidative stress. Antioxidants redox signal 31:75\u201391. https:\/\/doi.org\/10.1089\/ars.2018.7620","journal-title":"Antioxidants redox signal"},{"key":"5670_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00640-8","volume":"18","author":"E Barroso","year":"2020","unstructured":"Barroso E, Rodr\u00edguez-Rodr\u00edguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer X et al (2020) SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1\u03b1-LIPIN 1 pathway and increasing CD36 through Nrf2. Cell Commun Signal 18:147. https:\/\/doi.org\/10.1186\/s12964-020-00640-8","journal-title":"Cell Commun Signal"},{"key":"5670_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111778","volume":"140","author":"H Wang","year":"2021","unstructured":"Wang H, Wang L, Li Y, Luo S, Ye J, Lu Z et al (2021) The HIF-2\u03b1\/PPAR\u03b1 pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis. Biomed Pharmacother 140:111778. https:\/\/doi.org\/10.1016\/j.biopha.2021.111778","journal-title":"Biomed Pharmacother"},{"key":"5670_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/BSR20180059","volume":"38","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Xiao X, Zheng J, Li M, Yu M, Ping F et al (2018) Liraglutide protects cardiac function in diabetic rats through the PPAR\u03b1 pathway. Biosci Rep 38:59. https:\/\/doi.org\/10.1042\/BSR20180059","journal-title":"Biosci Rep"},{"key":"5670_CR39","doi-asserted-by":"publisher","first-page":"101762","DOI":"10.1016\/j.molmet.2023.101762","volume":"75","author":"W Guo","year":"2023","unstructured":"Guo W, Xu Z, Zou H, Li F, Li Y, Feng J et al (2023) Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog. Mol Metab 75:101762. https:\/\/doi.org\/10.1016\/j.molmet.2023.101762","journal-title":"Mol Metab"},{"key":"5670_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409781","volume":"12","author":"S Tian","year":"2024","unstructured":"Tian S, Zhou S, Wu W, Lin Y, Wang T, Sun H et al (2024) GLP-1 receptor agonists alleviate diabetic kidney injury via \u03b2-Klotho-mediated ferroptosis inhibition. Adv Sci 12:e2409781. https:\/\/doi.org\/10.1002\/advs.202409781","journal-title":"Adv Sci"},{"key":"5670_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157239","author":"A Lymperopoulos","year":"2025","unstructured":"Lymperopoulos A, Altsman VL, Stoicovy RA (2025) Glucagon-like peptide-1 receptor (GLP-1R) signaling: making the case for a functionally Gs protein-selective GPCR. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26157239","journal-title":"Int J Mol Sci"},{"key":"5670_CR42","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3892\/ijmm.2019.4272","volume":"44","author":"JY Jeon","year":"2019","unstructured":"Jeon JY, Choi S-E, Ha ES, Lee HB, Kim TH, Han SJ et al (2019) GLP\u20131 improves palmitate\u2013induced insulin resistance in human skeletal muscle via SIRT1 activity. Int J Mol Med 44:1161\u20131171. https:\/\/doi.org\/10.3892\/ijmm.2019.4272","journal-title":"Int J Mol Med"},{"key":"5670_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3094642","author":"Y-S Lee","year":"2016","unstructured":"Lee Y-S, Jun H-S (2016) Anti-inflammatory effects of GLP-1-based therapies beyond glucose control. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2016\/3094642","journal-title":"Mediators Inflamm"},{"key":"5670_CR44","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13994","volume":"7","author":"L Liljedahl","year":"2019","unstructured":"Liljedahl L, Pedersen MH, McGuire JN, James P (2019) The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome. Physiol Rep 7:e13994. https:\/\/doi.org\/10.14814\/phy2.13994","journal-title":"Physiol Rep"},{"key":"5670_CR45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ki.2013.427","volume":"85","author":"H Fujita","year":"2014","unstructured":"Fujita H, Morii T, Fujishima H, Sato T, Shimizu T, Hosoba M et al (2014) The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney Int 85:579\u2013589. https:\/\/doi.org\/10.1038\/ki.2013.427","journal-title":"Kidney Int"},{"key":"5670_CR46","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","volume":"54","author":"R Kodera","year":"2011","unstructured":"Kodera R, Shikata K, Kataoka HU, Takatsuka T, Miyamoto S, Sasaki M et al (2011) Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia 54:965\u2013978. https:\/\/doi.org\/10.1007\/s00125-010-2028-x","journal-title":"Diabetologia"},{"key":"5670_CR47","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/dom.12884","volume":"19","author":"BJ von Scholten","year":"2017","unstructured":"von Scholten BJ, Persson F, Rosenlund S, Eugen-Olsen J, Pielak T, Faber J et al (2017) Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: a sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial. Diabetes Obes Metab 19:901\u2013905. https:\/\/doi.org\/10.1111\/dom.12884","journal-title":"Diabetes Obes Metab"},{"key":"5670_CR48","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/antiox10050741","volume":"10","author":"K Kim","year":"2021","unstructured":"Kim K, Lee E-Y (2021) Excessively enlarged mitochondria in the kidneys of diabetic nephropathy. Antioxid (Basel) 10:741. https:\/\/doi.org\/10.3390\/antiox10050741","journal-title":"Antioxid (Basel)"},{"key":"5670_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.706832","volume":"9","author":"W Dai","year":"2021","unstructured":"Dai W, Lu H, Chen Y, Yang D, Sun L, He L (2021) The loss of mitochondrial quality control in diabetic kidney disease. Front Cell Dev Biol 9:706832. https:\/\/doi.org\/10.3389\/fcell.2021.706832","journal-title":"Front Cell Dev Biol"},{"key":"5670_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155195","volume":"131","author":"L Yao","year":"2022","unstructured":"Yao L, Liang X, Qiao Y, Chen B, Wang P, Liu Z (2022) Mitochondrial dysfunction in diabetic tubulopathy. Metabolism 131:155195. https:\/\/doi.org\/10.1016\/j.metabol.2022.155195","journal-title":"Metabolism"},{"key":"5670_CR51","doi-asserted-by":"publisher","first-page":"F852","DOI":"10.1152\/ajprenal.00181.2019","volume":"317","author":"Y-Y Yang","year":"2019","unstructured":"Yang Y-Y, Gong D-J, Zhang J-J, Liu X-H, Wang L (2019) Diabetes aggravates renal ischemia-reperfusion injury by repressing mitochondrial function and PINK1\/Parkin-mediated mitophagy. Am J Physiol Ren Physiol 317:F852\u2013F864. https:\/\/doi.org\/10.1152\/ajprenal.00181.2019","journal-title":"Am J Physiol Ren Physiol"},{"key":"5670_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-017-0127-z","volume":"9","author":"K Chen","year":"2018","unstructured":"Chen K, Dai H, Yuan J, Chen J, Lin L, Zhang W et al (2018) Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Cell Death Dis 9:105. https:\/\/doi.org\/10.1038\/s41419-017-0127-z","journal-title":"Cell Death Dis"},{"key":"5670_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13677","volume":"16","author":"VJ Old","year":"2025","unstructured":"Old VJ, Davies MJ, Papamargaritis D, Choudhary P, Watson EL (2025) The effects of glucagon-like peptide-1 receptor agonists on mitochondrial function within skeletal muscle: a systematic review. J Cachexia Sarcopenia Muscle 16:e13677. https:\/\/doi.org\/10.1002\/jcsm.13677","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5670_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132499","volume":"10","author":"W Wu","year":"2015","unstructured":"Wu W, Xu H, Wang Z, Mao Y, Yuan L, Luo W et al (2015) PINK1-Parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury. PLoS One 10:e0132499. https:\/\/doi.org\/10.1371\/journal.pone.0132499","journal-title":"PLoS One"},{"key":"5670_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111560","volume":"545","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang S, Chen X, Wang Z, Wang X, Zhou Q et al (2022) Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1\/Parkin-dependent mitophagy. Mol Cell Endocrinol 545:111560. https:\/\/doi.org\/10.1016\/j.mce.2022.111560","journal-title":"Mol Cell Endocrinol"},{"key":"5670_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.589114","volume":"11","author":"HR Zhou","year":"2020","unstructured":"Zhou HR, Ma XF, Lin WJ, Hao M, Yu X-Y, Li H-X et al (2020) Neuroprotective role of GLP-1 analog for retinal ganglion cells via PINK1\/Parkin-mediated mitophagy in diabetic retinopathy. Front Pharmacol 11:589114. https:\/\/doi.org\/10.3389\/fphar.2020.589114","journal-title":"Front Pharmacol"},{"key":"5670_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2019.04.029","volume":"705","author":"S Miller","year":"2019","unstructured":"Miller S, Muqit MMK (2019) Therapeutic approaches to enhance PINK1\/Parkin mediated mitophagy for the treatment of Parkinson\u2019s disease. Neurosci Lett 705:7\u201313. https:\/\/doi.org\/10.1016\/j.neulet.2019.04.029","journal-title":"Neurosci Lett"},{"key":"5670_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091356","volume":"10","author":"A-G Lazar","year":"2021","unstructured":"Lazar A-G, Vlad M-L, Manea A, Simionescu M, Manea S-A (2021) Activated histone acetyltransferase p300\/CBP-related signalling pathways mediate up-regulation of NADPH oxidase, inflammation, and fibrosis in diabetic kidney. Antioxidants 10:1356. https:\/\/doi.org\/10.3390\/antiox10091356","journal-title":"Antioxidants"},{"key":"5670_CR59","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.2337\/db20-0382","volume":"69","author":"A Bansal","year":"2020","unstructured":"Bansal A, Balasubramanian S, Dhawan S, Leung A, Chen Z, Natarajan R (2020) Integrative omics analyses reveal epigenetic memory in diabetic renal cells regulating genes associated with kidney dysfunction. Diabetes 69:2490\u20132502. https:\/\/doi.org\/10.2337\/db20-0382","journal-title":"Diabetes"},{"key":"5670_CR60","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0076-6879(04)82019-6","volume":"382","author":"P Talalay","year":"2004","unstructured":"Talalay P, Dinkova-Kostova AT (2004) Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates. Methods Enzymol 382:355\u2013364","journal-title":"Methods Enzymol"},{"key":"5670_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0041-008X(92)90273-U","volume":"112","author":"TJ Monks","year":"1992","unstructured":"Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG (1992) Quinone chemistry and toxicity. Toxicol Appl Pharmacol 112:2\u201316","journal-title":"Toxicol Appl Pharmacol"},{"key":"5670_CR62","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1074\/jbc.M115.668699","volume":"291","author":"AS Madsen","year":"2016","unstructured":"Madsen AS, Andersen C, Daoud M, Anderson KA, Laursen JS, Chakladar S et al (2016) Investigating the Sensitivity of NAD+-dependent sirtuin deacylation activities to NADH. J Biol Chem 291:7128\u20137141. https:\/\/doi.org\/10.1074\/jbc.M115.668699","journal-title":"J Biol Chem"},{"key":"5670_CR63","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1128\/MCB.01483-13","volume":"34","author":"SA Samant","year":"2014","unstructured":"Samant SA, Zhang HJ, Hong Z, Pillai VB, Sundaresan NR, Wolfgeher D et al (2014) SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol Cell Biol 34:807\u2013819. https:\/\/doi.org\/10.1128\/MCB.01483-13","journal-title":"Mol Cell Biol"},{"key":"5670_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112861","volume":"408","author":"L Shen","year":"2021","unstructured":"Shen L, Zhang Q, Tu S, Qin W (2021) SIRT3 mediates mitofusin 2 ubiquitination and degradation to suppress ischemia reperfusion-induced acute kidney injury. Exp Cell Res 408:112861. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112861","journal-title":"Exp Cell Res"},{"key":"5670_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41418-019-0356-z","volume":"27","author":"T Zhang","year":"2020","unstructured":"Zhang T, Liu J, Shen S, Tong Q, Ma X, Lin L (2020) SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. Cell Death Differ 27:329\u2013344. https:\/\/doi.org\/10.1038\/s41418-019-0356-z","journal-title":"Cell Death Differ"},{"key":"5670_CR66","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/jcp.31069","volume":"238","author":"R Li","year":"2023","unstructured":"Li R, Wang Z, Wang Y, Sun R, Zou B, Tian X et al (2023) SIRT3 regulates mitophagy in liver fibrosis through deacetylation of PINK1\/NIPSNAP1. J Cell Physiol 238:2090\u20132102. https:\/\/doi.org\/10.1002\/jcp.31069","journal-title":"J Cell Physiol"},{"key":"5670_CR67","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/hepr.12634","volume":"46","author":"W Tong","year":"2016","unstructured":"Tong W, Ju L, Qiu M, Xie Q, Chen Y, Shen W et al (2016) Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1\/SIRT3-FOXO3a pathway. Hepatol Res 46:933\u2013943. https:\/\/doi.org\/10.1111\/hepr.12634","journal-title":"Hepatol Res"},{"key":"5670_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2022.129381","volume":"437","author":"D Wang","year":"2022","unstructured":"Wang D, Cao L, Zhou X, Wang G, Ma Y, Hao X et al (2022) Mitigation of honokiol on fluoride-induced mitochondrial oxidative stress, mitochondrial dysfunction, and cognitive deficits through activating AMPK\/PGC-1\u03b1\/Sirt3. J Hazard Mater 437:129381. https:\/\/doi.org\/10.1016\/j.jhazmat.2022.129381","journal-title":"J Hazard Mater"},{"key":"5670_CR69","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s12265-020-09984-5","volume":"14","author":"RA Eid","year":"2021","unstructured":"Eid RA, Bin-Meferij MM, El-Kott AF, Eleawa SM, Zaki MSA, Al-Shraim M et al (2021) Exendin-4 protects against myocardial ischemia-reperfusion injury by upregulation of SIRT1 and SIRT3 and activation of AMPK. J Cardiovasc Transl Res 14:619\u2013635. https:\/\/doi.org\/10.1007\/s12265-020-09984-5","journal-title":"J Cardiovasc Transl Res"},{"key":"5670_CR70","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbrc.2020.03.032","volume":"525","author":"X Han","year":"2020","unstructured":"Han X, Ding C, Zhang G, Pan R, Liu Y, Huang N et al (2020) Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2\/HO-1 pathway. Biochem Biophys Res Commun 525:895\u2013901. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.032","journal-title":"Biochem Biophys Res Commun"},{"key":"5670_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117048","volume":"491","author":"M-D Ewees","year":"2024","unstructured":"Ewees M-D, Mostafa-Hadeab G, Saber S, El-Meguid EAA, Sree HTA, Abdel Rahman F-Z et al (2024) Linagliptin mitigates cisplatin-induced kidney impairment via mitophagy regulation in rats, with emphasis on SIRT-3\/PGC-1\u03b1, PINK-1 and Parkin-2. Toxicol Appl Pharmacol 491:117048. https:\/\/doi.org\/10.1016\/j.taap.2024.117048","journal-title":"Toxicol Appl Pharmacol"},{"key":"5670_CR72","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin E (2015) NAD\u207a in aging, metabolism, and neurodegeneration. Sci (New York NY) 350:1208\u20131213. https:\/\/doi.org\/10.1126\/science.aac4854","journal-title":"Sci (New York NY)"},{"key":"5670_CR73","doi-asserted-by":"publisher","first-page":"e2411235","DOI":"10.1002\/advs.202411235","volume":"1","author":"Y Xi","year":"2025","unstructured":"Xi Y, Tao K, Wen X, Feng D, Mai Z, Ding H et al (2025) SIRT3-mediated deacetylation of DRP1K711 prevents mitochondrial dysfunction in Parkinson\u2019s disease. Adv Sci (Weinh) 1:e2411235. https:\/\/doi.org\/10.1002\/advs.202411235","journal-title":"Adv Sci (Weinh)"},{"key":"5670_CR74","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41419-021-03666-z","volume":"12","author":"L Feng","year":"2021","unstructured":"Feng L, Chen M, Li Y, Li M, Hu S, Zhou B et al (2021) Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis. Cell Death Dis 12:405. https:\/\/doi.org\/10.1038\/s41419-021-03666-z","journal-title":"Cell Death Dis"},{"key":"5670_CR75","doi-asserted-by":"publisher","first-page":"20499","DOI":"10.1074\/jbc.M115.666354","volume":"290","author":"WJ Liu","year":"2015","unstructured":"Liu WJ, Shen TT, Chen RH, Wu H-L, Wang YJ, Deng JK et al (2015) Autophagy-lysosome pathway in renal tubular epithelial cells is disrupted by advanced glycation end products in diabetic nephropathy. J Biol Chem 290:20499\u201320510. https:\/\/doi.org\/10.1074\/jbc.M115.666354","journal-title":"J Biol Chem"},{"key":"5670_CR76","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bcp.2006.10.016","volume":"73","author":"D Gonz\u00e1lez-Arag\u00f3n","year":"2006","unstructured":"Gonz\u00e1lez-Arag\u00f3n D, Ariza J, Villalba JM (2006) Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells. Biochem Pharmacol 73:427\u2013439","journal-title":"Biochem Pharmacol"},{"key":"5670_CR77","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1535-7163.MCT-07-0457","volume":"7","author":"A Hern\u00e1ndez","year":"2008","unstructured":"Hern\u00e1ndez A, L\u00f3pez-Lluch G, Bernal JA, Navas P, Pintor-Toro JA (2008) Dicoumarol down-regulates human PTTG1\/Securin mRNA expression through inhibition of Hsp90. Mol Cancer Ther 7:474\u2013482. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-0457","journal-title":"Mol Cancer Ther"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05670-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:10Z","timestamp":1791186310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05670-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5670"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05670-3","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by the Animal Ethics Committee of The First Hospital of Lanzhou University (Approval No: LDYYLL-2025-162) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}